High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates

American Journal of Psychiatry

Volumn 157, Issue 10, 2000, Pages 1619-1628

  Zubieta, J K ^a   Huguelet, P ^a   Ohl, L E ^a   Koeppe, R A ^a   Kilbourn, M R ^a   Carr, J M ^a   Giordani, B J ^a   Frey, K A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MONOAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MONOAMINE RELEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; SEX DIFFERENCE;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; BRAIN STEM; COGNITION DISORDERS; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MEMBRANE GLYCOPROTEINS; PRESYNAPTIC TERMINALS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRABENAZINE; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033797535     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.10.1619     Document Type: Article

References (70)

1. The significance of past mania or hypomania in the course and outcome of major depression
2. Course of affective disorders
3. Epidemiology of affective disorders: A reexamination and future directions
4. Genetics
5. Twelve month outcome after a first hospitalization for affective psychosis
6. Cognitive impairment in euthymic bipolar patients with and without alcohol dependence
7. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics
8. Paralimbic hypoperfusion in unipolar depression
9. Effect of sertraline on regional metabolic rate in patients with affective disorder
10. Reduction of prefrontal cortex glucose metabolism common to three types of depression
11. Subgenual prefrontal cortex abnormalities in mood disorders
12. Structural changes in the brain of patients with bipolar affective disorder by MRI: A review of the literature
13. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder
14. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients
15. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder
16. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS
17. 11C]dihydrotetrabenazine by dynamic PET: Measurement of vesicular monoamine transporter
18. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter
19. Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles
20. Expression and regulation of the bovine vesicular monoamine transporter gene
21. Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra
22. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments
23. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat
24. 3H]Methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity
25. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
26. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography
27. Modulatory role of catecholamines in the transsynaptic expression of c-fos in the rat medial prefrontal cortex induced by disinhibition of the mediodorsal thalamus: A study employing microdialysis and immunohistochemistry
28. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
29. The frontal cortex-basal ganglia system in primates
30. Neural correlates of attention and arousal: Insights from electrophysiology, functional neuroimaging and psychopharmacology
31. A rating scale for depression
32. A rating scale for mania: Reliability, validity and sensitivity
33. Revising axis V for DSM-IV: A review of measures of social functioning
34. 11C]dihydrotetrabenazine (DTBZ) and positron emission tomography
35. 11C]dihydrotetrabenazine (DTBZ)
36. 15O), I: Theory and error analysis
37. Automatic detection of the intercommissural line for stereotactic localization of functional brain images
38. 11C]dihydrotetrabenazine
39. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
40. Frontal lobe dysfunction in Parkinson's disease
41. Performance with multiple sets in Parkinson's disease
42. Influence of spatially heterogeneous background activity on 'hot object' quantitation in brain emission computed tomography
43. Striatal dopaminergic abnormalities in human cocaine users
44. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems
45. Vesicular neurotransmitter transporters: Potential sites for the regulation of synaptic function
46. Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system
47. Reduced central serotonin transporters in alcoholism
48. Awakening the sleeping giant: Anatomy and plasticity of the brain serotonergic system
49. SPECT imaging of dopamine and serotonin transporters with [123In]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
50. β-CIT SPECT demonstrates blockade of 5-HT uptake site by citalopram in the human brain in vivo
51. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat
52. Three-dimensional mapping of norepinephrine and serotonin in human thalamus
53. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder
54. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
55. Noradrenergically mediated plasticity in a human attentional neuronal network
56. Neurotransmitter actions in the thalamus and cerebral cortex
57. Fenfluramine depletes serotonin from the developing cortex and alters thalamocortical organization
58. Involvement of the pallidal-thalamocortical circuit in adaptive behavior
59. Thalamic deactivation during early implicit sequence learning: A functional MRI study
60. Functional MRI study of the cognitive generation of affect
61. Dopamine and the mechanisms of cognition, part II: D-amphetamine effects in human subjects performing a selective attention task
62. Dopamine and the mechanisms of cognition, part I: A neural network model predicting dopamine effects on selective attention
63. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers
64. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones
65. The course of affective disorders, II: Typology of bipolar manic-depressive illness